Skip to main content

Table 1 Clinical characteristics of the two groups

From: A preliminary study on the diagnostic value of PSADR, DPC and TSRP in the distinction of prostatitis and prostate cancer

 

PCa

Prostatitis

t/Z

P

Age (year)

72.26 ± 1.02

66.52 ± 1.01

-3.965

 < 0.001

Blood white cell count (× 109 /L)

7.09 ± 0.51

8.23 ± 0.59

-1.701

0.089

Blood neutrophil count (× 109 /L)

4.76 ± 0.47

6.03 ± 0.57

-1.713

0.087

Percentage of neutrophils (%)

64.20 ± 9.72

70.24 ± 2.35

2.217

0.024

Percentage of lymphocytes (%)

26.03 ± 8.14

21.08 ± 2.20

-1.994

0.050

Monocyte percentage (%)

6.63 ± 1.78

6.06 ± 0.44

-1.164

0.248

Urinary white blood cell count (/μL)

128.27 ± 66.34

625.93 ± 387.76

-2.446

0.014

Urinary bacterial count (/μL)

1877.06 ± 1256.44

4152.68 ± 1984.34

-1.560

0.119

Prostate volume (cm3)

44.15 ± 3.63

77.11 ± 6.60

-4.276

 < 0.001

PSADR (ng/mL/week)

-1.96 ± 1.61

12.14 ± 2.38

-5.926

 < 0.001

TSRP

2.61 ± 0.11

2.16 ± 0.10

-3.206

0.001

DPC

1.16 ± 0.02

1.09 ± 0.03

-3.394

0.001

The forecast probability

0.78 ± 0.36

0.27 ± 0.04

-6.490

 < 0.001

  1. Note: PSADR Weekly Decline Rate of PSA, DPC Degree of Prostate Collapse, TSRP Prostate Tissue Signal Ratio